Argus Research Remains a Hold on Clorox (CLX)We also note the difficult consumer environment which has pressured consumers to spend more cautiously and some to trade down. As CLX laps incremental shipment benefits from the ERP transition in FY25, management is guiding for organic sales to be down 5%-9% for the year. On the positive side, we have a favorable view of the company’s IGNITE strategy, which aims to accelerate innovation in key areas of the business and integrate environmental, social, and governance priorities into decision-making. We also like the investment in the company’s digital capabilities and productivity enhancements to support margin growth.